Alternatively, hold down the Ctrl strong> '/' CMD 'key and press + to enlarge or' - 'on the keyboard to reduce the text size.

100%

High contrast mode is an accessibility feature for people with visual impairment.

Protection against falsified medicine

The objective of EU Directive 2011/62 is to protect prescription-only medicinal products from being falsified. Packaging for such medicinal products will bear new safety features and a unique identifier. Throughout EU a common repositories system will verify prescriptive drugs before it is delivered to a patient.

Protection against falsified medicine

The objective of EU Directive 2011/62 is to protect prescription-only medicinal products from being falsified. Packaging for such medicinal products will bear new safety features and a unique identifier. Throughout EU a common repositories system will verify prescriptive drugs before it is delivered to a patient.

The deadline is February 2019

From February 9th 2019, it will no longer be possible for falsifiers to introduce falsified, and sometimes life-threatening products, into the legal supply chain. Read more about the medicines supply chain and general information about the new regulations here:

The new regulations is in effect

Timeline

The Norwegian NMVS is connected to the EU HUB

Information meeting October 24th for all stakeholders

EU Directive implemented (2019)

News and project updates

See more news and project updates

Systemet er nå oppe og går – slik har starten vært

På lørdag ble det nye systemet som skal hindre falske legemidler i å komme inn i forsyningskjeden, skrudd på. - Det har vært en rolig og god start i helgen. Systemet fungerer godt.

Continue reading
See more project updates